REVERSAL OF GASTROINTESTINAL, TOXICITY ASSOCIATED WITH LONG-TERM FK506 IMMUNOSUPPRESSION BY CONVERSION TO CYCLOSPORINE IN LIVER-TRANSPLANT RECIPIENTS

被引：10
|
作者：
MOR, E
SCHWERSENZ, A
SHEINER, PA
EMRE, S
SCHWARTZ, ME
MILLER, CM
机构：
[1] CUNY MT SINAI SCH MED,DEPT SURG,NEW YORK,NY 10029
[2] CUNY MT SINAI SCH MED,DEPT PEDIAT,NEW YORK,NY 10029
来源：
TRANSPLANTATION | 1994年 / 57卷 / 07期
关键词：
D O I：
10.1097/00007890-199404150-00025
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：1130 / 1132
页数：3
相关论文
共 50 条
  • [1] LONG-TERM EFFECTS OF FK506 FOLLOWING CONVERSION FROM CYCLOSPORINE TO FK506 FOR CHRONIC REJECTION IN LIVER-TRANSPLANT RECIPIENTS
    FUNG, JJ
    JAIN, A
    HAMMAD, I
    DOYLE, H
    SELBY, R
    TZAKIS, AG
    TODO, S
    STARZL, TE
    HEPATOLOGY, 1993, 18 (04) : A74 - A74
  • [2] REVERSIBILITY OF NEPHROTOXICITY AND SEVERE GASTROINTESTINAL SYMPTOMS ASSOCIATED WITH FK506 IMMUNOSUPPRESSION IN LIVER-TRANSPLANT RECIPIENTS
    MOR, E
    KOLESNIKOV, V
    SHEINER, P
    SCHWARTZ, M
    EMRE, S
    MILLER, C
    HEPATOLOGY, 1993, 18 (03) : 734 - 734
  • [3] DIABETOGENICITY OF FK506 VERSUS CYCLOSPORINE IN LIVER-TRANSPLANT RECIPIENTS
    JINDAL, RM
    POPESCU, I
    SCHWARTZ, ME
    EMRE, S
    BOCCAGNI, P
    MILLER, CM
    TRANSPLANTATION, 1994, 58 (03) : 370 - 372
  • [4] GASTROINTESTINAL TOXICITY ASSOCIATED WITH FK-506 IN LIVER-TRANSPLANT RECIPIENTS
    FISHER, A
    SCHWARTZ, M
    MOR, E
    SHEINER, P
    EMRE, S
    GUY, S
    MILLER, C
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (06) : 3106 - 3107
  • [5] PRIMARY IMMUNOSUPPRESSION WITH FK506 VERSUS CYCLOSPORINE A (CYA) IN LIVER-TRANSPLANT RECIPIENTS - INCIDENCE AND SEVERITY OF CELLULAR REJECTION
    WIESNER, RH
    HEPATOLOGY, 1993, 18 (04) : A57 - A57
  • [6] SYSTEMIC AND RENAL HEMODYNAMIC DIFFERENCES BETWEEN FK506 AND CYCLOSPORINE IN LIVER-TRANSPLANT RECIPIENTS
    TEXTOR, SC
    WIESNER, R
    WILSON, DJ
    PORAYKO, M
    ROMERO, JC
    BURNETT, JC
    GORES, G
    HAY, E
    DICKSON, ER
    KROM, RA
    TRANSPLANTATION, 1993, 55 (06) : 1332 - 1339
  • [7] LATE EFFECTS OF CYCLOSPORINE AND FK506 ON LIPID-METABOLISM IN LIVER-TRANSPLANT RECIPIENTS
    MOR, E
    ATILLASOV, E
    KREIZMAN, I
    KOLESNIKOV, V
    MORAN, V
    SCHWARTZ, B
    SHEINER, PA
    SCHWARTZ, ME
    MILLER, CM
    BERK, P
    HEPATOLOGY, 1994, 20 (04) : A123 - A123
  • [8] DIABETOGENICITY OF FK506 VERSUS CYA IN LIVER-TRANSPLANT RECIPIENTS
    JINDAL, RM
    EMRE, S
    MENESES, P
    MOR, E
    KADIAN, M
    KISHIKAWA, K
    SCHWARTZ, M
    MILLER, CM
    HEPATOLOGY, 1993, 18 (03) : 745 - 745
  • [9] NEPHROTOXICITY OF FK-506 AND CYCLOSPORINE WHEN USED AS PRIMARY IMMUNOSUPPRESSION IN LIVER-TRANSPLANT RECIPIENTS
    PORAYKO, MK
    TEXTOR, SC
    KROM, RAF
    HAY, JE
    GORES, GJ
    WAHLSTROM, HE
    SANCHEZURDAZPAL, L
    RICHARDS, T
    CROTTY, P
    BEAVER, S
    WIESNER, RH
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (01) : 665 - 668
  • [10] INFECTIONS IN ADULT LIVER-TRANSPLANT PATIENTS UNDER FK506 IMMUNOSUPPRESSION
    ALESSIANI, M
    KUSNE, S
    MARTIN, M
    JAIN, A
    ABUELMAGD, K
    MOSER, J
    TODO, S
    FUNG, J
    STARZL, T
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 1501 - 1503
12345